AstraZeneca’s Ultomiris reduces urine protein in late-stage trial of rare kidney disease Reuters
Astrazeneca’s Ultomiris Reduces Urine Protein in Late-stage Trial of Rare Kidney Disease
AstraZeneca's Ultomiris reduces urine protein in late-stage trial of rare kidney disease Reuters